Mechanistic approaches to chemoprevention of mutation and cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 591, Issue 1-2, 2005, Pages 3-7

  Ferguson, Lynnette R ^a   Bronzetti, Giorgio ^b   De Flora, Silvio ^c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b CNR   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Antiangiogenesis; Anticarcinogen; Antimutagen; Apoptosis; DNA repair enzymes; Glutathione S transferases

Indexed keywords

3 INDOLEMETHANOL; ACETYLCYSTEINE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BETA NAPHTHOFLAVONE; BIOLOGICAL MARKER; CAFESTOL; CAFFEIC ACID PHENETHYL ESTER; CATECHIN; EPIGALLOCATECHIN GALLATE; ESTRADIOL; GLUTATHIONE TRANSFERASE; KAHWEOL; NONSTEROID ANTIINFLAMMATORY AGENT; OLTIPRAZ; PHENETHYL ISOTHIOCYANATE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; POLYPHENOL; PROBIOTIC AGENT; RESVERATROL; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SELENIUM; SULINDAC; TAMOXIFEN; THIOL DERIVATIVE;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; CLINICAL TRIAL; DRUG EFFECT; DRUG MECHANISM; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; INFLAMMATION; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RED WINE; REVIEW; SCREENING; TEA;

EID: 27844495199     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2005.05.017     Document Type: Editorial

References (37)

1. S. De Flora Role and mechanisms of inhibitors in prevention of mutation and cancer Mutat. Res. 202 1988 277 449
2. S. De Flora G. Bronzetti F.H. Sobels Assessment of antimutagenicity and anticarcinogenicity: end-points and systems Mutat. Res. 267 1992 153 298
3. R.C. von Borstel J.W. Drake L.H. Loeb Mechanisms of antimutagenesis and anticarcinogenesis Mutat. Res. 350 1996 1 293
4. H. Hayatsu Antimutagenesis: present and future trends Mutat. Res. 402 1998 1 337
5. J.M. Gentile G. Gentile P.H.M. Lohman L.R. Ferguson Antimutagenesis/ anticarcinogenesis 2001: mechanistic studies Mutat. Res. 480-481 2001 1 380
6. P.H.M. Lohman J.M. Gentile G. Gentile L.R. Ferguson Antimutagenesis/ anticarcinogenesis 2001: screening, methods and biomarkers Mutat. Res. 496 2001 1 230
7. Y.-J. Surh L.R. Ferguson Dietary and medicinal antimutagens and anticarcinogens: molecular mechanisms and chemopreventive potential Mutat. Res. 523-524 2003 1 278
8. S. De Flora, and L.R. Ferguson Overview of mechanisms of cancer chemopreventive agents Mutat. Res. 591 2005 8 15
9. G. Kelloff, and V. Steel Development of cancer chemopreventive drugs based on mechanistic approaches Mutat. Res. 591 2005 16 23
10. T. Gichner, and J. Velemínský Mechanisms of inhibition of N-nitroso compounds-induced mutagenicity Mutat. Res. 202 1988 325 334
11. F. Oesch Antimutagenesis by shift in monooxygenase isoenzymes and induction of epoxide hydrolase Mutat. Res. 202 1988 335 342
12. Y. Kuroda, and T. Inoue Antimutagenesis by factors affecting DNA repair in bacteria Mutat. Res. 202 1988 387 391
13. L.A. Mitscher, H. Telikepalli, E. McGhee, and D.M. Shankel Natural antimutagenic agents Mutat. Res. 350 1996 143 152
14. H. Hayatsu, S. Arimoto, and T. Negishi Dietary inhibitors of mutagenesis and carcinogenesis Mutat. Res. 202 1988 429 446
15. L.R. Ferguson, and P.J. Harris Studies on the role of specific dietary fibres in protection against colorectal cancer Mutat. Res. 350 1996 173 184
16. L.R. Ferguson, and S. De Flora Multiple drug resistance, antimutagenesis and anticarcinogenesis Mutat. Res. 591 2005 24 33
17. H. Bartsch, and J. Nair Accumulation of lipid peroxidation-derived DNA-lesions: potential lead markers for chemoprevention of inflammation-driven malignancies Mutat. Res. 591 2005 34 44
18. M. Dizdaroglu Base-excision repair of oxidative DNA damage by DNA glycosylases Mutat. Res. 591 2005 45 59
19. T. Nohmi, S.-R. Kim, and M. Yamada Modulation of oxidative mutagenesis and carcinogenesis by polymorphic forms of human DNA repair enzymes Mutat. Res. 591 2005 60 73
20. B. Pool-Zobel, S. Veeriah, and F.-D. Böhmer Modulation of xenobiotic metabolising enzymes by anticarcinogens - focus on glutathione S-transferases and their role as targets of chemoprevention in colorectal carcinogenesis Mutat. Res. 591 2005 74 92
21. X. Yu, and T. Kensler Nrf2 as a target for cancer chemoprevention Mutat. Res. 591 2005 93 102
22. N. Zanesi, Y. Pekarsky, and C.M. Croce A mouse model of the fragile gene FHIT: from carcinogenesis to gene therapy and cancer prevention Mutat. Res. 591 2005 103 109
23. H. Ohshima, H. Tazawa, B. Sylla, and T. Sawa Prevention of human cancer by modulation of chronic inflammatory processes Mutat. Res. 591 2005 110 122
24. J.K. Kundu, and Y.-J. Surh Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals Mutat. Res. 591 2005 123 146
25. B. Weinstein, and M. Shimizu Modulation of signal transduction by tea catechins and related phytochemicals Mutat. Res. 591 2005 147 160
26. W.-M. Dashwood, O. Carter, M. Al-Fageeh, Q. Li, and R.H. Dashwood Lysosomal trafficking of β-catenin induced by the tea polyphenol epigallocatechin-3-gallate Mutat. Res. 591 2005 161 172
27. F. D'Agostini, A. Izzotti, R.M. Balansky, C. Bennicelli, and S. De Flora Modulation of apoptosis by cancer chemopreventive agents Mutat. Res. 591 2005 173 186
28. J.E. Trosko, C.-C. Chang, B.L. Upham, and M.-H. Tai The role of human adult stem cells and cell-cell communication in cancer chemoprevention and chemotherapy strategies Mutat. Res. 591 2005 187 197
29. U. Pfeffer, N. Ferrari, R. Dell'Eva, S. Indraccolo, M. Morini, D.M. Noonan, and A. Albini Molecular mechanisms of angiopreventive compounds: microarray gene expression analyses Mutat. Res. 591 2005 198 211
30. A. Izzotti, M. Bagnasco, C. Cartiglia, M. Longobardi, A. Camoirano, E. Tampa, R.A. Lubet, and S. De Flora Modulation of multigene expression and proteome profiles by chemopreventive agents Mutat. Res. 591 2005 212 223
31. K. El-Bayoumy, and R. Sinha Modulation of multigene expression by selenium Mutat Res. 591 2005 224 236
32. P. Dolara, C. Luceri, C. De Filippo, A. Pietro Femia, L. Giovannelli, G. Caderni, C. Cecchini, S. Silvi, C. Orpianesi, and A. Cresci Red wine polyphenols influence carcinogenesis, oxidation damage, intestinal microflora and colonic gene expression profiles in F344 rats Mutat. Res. 591 2005 237 246
33. C. Jordan, and J. Lewis Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance Mutat. Res. 591 2005 247 263
34. H. Steinkeller, C. Hoelzl, M. Uhl, C. Cavin, G. Haidinger, A. Gsur, R. Schmid, M. Kundi, J. Bichler, and S. Knasmuller Coffee consumption induces GST pi and protects against (±)-anti-benzo[a]pyrene-7,8-dihydrodiol-9,10- epoxide induced DNA damage in humans Mutat. Res. 591 2005 264 275
35. I. Rowlands, D. Commane, R. Hughes, and C. Shortt The potential mechanisms involved in the anticarcinogenic action of probiotics Mutat. Res. 591 2005 276 289
36. W. Greenrod, C.S. Stockley, P. Burcham, M. Abbey, and M. Fenech Moderate acute intake of de-alcoholised red wine, but not alcohol, is protective against radiation-induced DNA damage ex vivo-results of a comparative in vivo intervention study in younger men Mutat. Res. 591 2005 290 301
37. R.J. Sram, B. Binkova, Z. Stavkova, I. Solansky, and J. Dejmek The impact of plasma folic acid levels of mothers and newborns on intrauterine growth retardation and birth weight Mutat. Res. 591 2005 302 310